Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2/EP4 pathway
- PMID: 35588334
- PMCID: PMC11071853
- DOI: 10.1007/s00018-022-04319-w
Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2/EP4 pathway
Abstract
The pathogenesis of liver fibrosis in nonalcoholic fatty liver disease (NAFLD) remains unclear and the effective treatments have not been explored yet. The activation of hepatic stellate cells (HSCs) is considered as the most critical factor in the progression of liver fibrosis and cirrhosis. Autophagy has recently been identified as a new mechanism to regulate HSC activation. Here, we found that liver macrophages were polarized toward type 2 (M2) during the progression of nonalcoholic steatohepatitis (NASH) and liver fibrosis in both patients and NAFLD mice. Using the methionine-choline-deficient (MCD) diet NAFLD murine model and the in vitro cell culture system, we identified that the M2 macrophages promoted HSC autophagy by secreting prostaglandin E2 (PGE2) and binding its receptor EP4 on the surface of HSCs, which consequently enhanced HSC activation, extracellular matrix deposition, and liver fibrosis. Mechanistically, PGE2/EP4 signals enhanced HSC autophagy through the Erk pathway. A specific PGE2/EP4 antagonist E7046 significantly inhibited M2 macrophage-mediated HSC autophagy and improved liver fibrosis and histopathology in NAFLD mice. Our study provides novel mechanistic insights into the regulation of HSC activation and liver fibrosis. Our findings suggest that the PGE2/EP4 pathway is a promising therapeutic target to prevent NASH progression into cirrhosis.
Keywords: Autophagy; E7046; Erk1/2; Macrophage polarization; Type 2 macrophage.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
The authors declare no competing of interest.
Figures









Similar articles
-
Macrophages produce PGE2 to promote hepatic stellate cell autophagy and liver fibrosis.Autophagy Rep. 2022 Sep 4;1(1):389-392. doi: 10.1080/27694127.2022.2119513. eCollection 2022. Autophagy Rep. 2022. PMID: 40396000 Free PMC article.
-
Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.Liver Int. 2022 Dec;42(12):2696-2712. doi: 10.1111/liv.15441. Epub 2022 Oct 11. Liver Int. 2022. PMID: 36165186
-
Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways.Biomed Pharmacother. 2024 Aug;177:116952. doi: 10.1016/j.biopha.2024.116952. Epub 2024 Jun 24. Biomed Pharmacother. 2024. PMID: 38917754
-
Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.Front Endocrinol (Lausanne). 2021 Dec 6;12:773432. doi: 10.3389/fendo.2021.773432. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34938271 Free PMC article. Review.
-
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.Gastroenterology. 2020 May;158(7):1913-1928. doi: 10.1053/j.gastro.2019.11.311. Epub 2020 Feb 8. Gastroenterology. 2020. PMID: 32044315 Free PMC article. Review.
Cited by
-
The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease.Front Endocrinol (Lausanne). 2024 Aug 8;15:1374644. doi: 10.3389/fendo.2024.1374644. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39175576 Free PMC article. Review.
-
Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells.J Natl Cancer Cent. 2024 Jan 18;4(1):25-35. doi: 10.1016/j.jncc.2024.01.002. eCollection 2024 Mar. J Natl Cancer Cent. 2024. PMID: 39036388 Free PMC article. Review.
-
Programmed cell death in hepatic fibrosis: current and perspectives.Cell Death Discov. 2023 Dec 12;9(1):449. doi: 10.1038/s41420-023-01749-8. Cell Death Discov. 2023. PMID: 38086792 Free PMC article. Review.
-
Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages.Front Pharmacol. 2022 Nov 16;13:1030800. doi: 10.3389/fphar.2022.1030800. eCollection 2022. Front Pharmacol. 2022. PMID: 36467025 Free PMC article.
-
Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells.Front Immunol. 2023 Jul 19;14:1204524. doi: 10.3389/fimmu.2023.1204524. eCollection 2023. Front Immunol. 2023. PMID: 37539053 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous